GCIA
IMGN

Gabelli & Co Investment Advisers’s Immunogen Inc IMGN Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-624,750
Closed -$18.5M – 295
2023
Q4 		$18.5M Buy
+624,750
New +$12.4M 3.48% 7

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gabelli & Co Investment Advisers's IMGN Position: Q1 2024 in Review

Gabelli & Co Investment Advisers sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 624,750 shares — an estimated $18.5M sold.

Gabelli & Co Investment Advisers first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $18.5M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Gabelli & Co Investment Advisers reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 624,750 Immunogen Inc shares in Q1 2024, an estimated $18.5M.
  • Gabelli & Co Investment Advisers first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's Immunogen Inc position peaked at $18.5M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2024, filed 14 May 2024.